LEADER 05177nam 22006974a 450 001 9910807482803321 005 20240402140142.0 010 $a1-281-37907-7 010 $a9786611379070 010 $a981-277-401-7 035 $a(CKB)1000000000407186 035 $a(EBL)1679331 035 $a(OCoLC)815571420 035 $a(SSID)ssj0000133986 035 $a(PQKBManifestationID)11954052 035 $a(PQKBTitleCode)TC0000133986 035 $a(PQKBWorkID)10045639 035 $a(PQKB)10257684 035 $a(MiAaPQ)EBC1679331 035 $a(WSP)00006062 035 $a(Au-PeEL)EBL1679331 035 $a(CaPaEBR)ebr10201457 035 $a(CaONFJC)MIL137907 035 $a(EXLCZ)991000000000407186 100 $a20060923d2006 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aCurrent review of Chinese medicine $equality control of herbs and herbal materials /$fchief editor, Ping-Chung Leung ; editors, Harry Fong, Charlie Changli Xue 205 $a1st ed. 210 $aHackensack, NJ $cWorld Scientific$dc2006 215 $a1 online resource (310 p.) 225 1 $aAnnals of traditional Chinese medicine ;$vv. 2 300 $aDescription based upon print version of record. 311 $a981-256-707-0 320 $aIncludes bibliographical references and index. 327 $aContents ; Contributors ; Preface to Series ; Chapter 1 The Basic Requirement for Modernisation of Chinese Herbal Medicine ; 1.1 Authentication of the Species Prone to Confusion ; 1.2 Quality Evaluation of the Crude Drugs ; 1.3 Distinguishing the Adulterant from the Authentic Sample 327 $a1.4 Monitoring Rationality of Dosage Forms During R&D Period 1.5 Monitoring the Dynamic Change Due to Interaction of Mixed Herbal Drugs During Extraction ; 1.6 Conclusion ; References ; Chapter 2 Evidence-Based Herbal Medicine: Challenges in Efficacy and Safety Assessments 327 $a2.1 Introduction 2.2 UIC/NIH Center for Botanical Dietary Supplements Research ; 2.3 Acquisition of Quality Source Materials ; 2.4 Selection of Appropriate Bioassays ; 2.5 Bioassay-Directed Isolation Bioactive Marker(s) ; 2.6 Standardisation of Pre-clinical and Clinical Extract 327 $a2.7 Production of Biologically and Chemically Standardised Dosage Forms 2.8 Pharmacokinetic and Bioavailability ; 2.9 Clinical Studies ; 2.10 Conclusion ; Acknowledgements ; References 327 $aChapter 3 Good Agricultural Practice - GAP Does it Ensure a Perfect Supply of Medicinal Herbs for Research and Drug Development? 3.1 Introduction ; 3.2 The Need for G.A.P. ; 3.3 China Recommendations ; 3.4 World Health Organization Recommendations ; 3.5 European Union Recommendations 327 $a3.6 The Current Situation of GAP in China 330 $a The second volume of this book series on the modern practice of Chinese medicine continues with the focus on evidence-based TCM research. It is focused on detailed information about the best sources of herbal supply and its quality control required for research and drug development purposes. Herbal quality has always been a major concern for TCM researchers because it is difficult to know which is of the best quality. Some other popular topics are also entertained. Sample Chapter(s)
Chapter 1: The Basic Requirement for Modernisation of Chinese Herbal Medicine (422 KB)

Co 410 0$aAnnals of traditional Chinese medicine ;$vv. 2. 606 $aMedicine, Chinese 606 $aHerbs$xTherapeutic use$xTesting 615 0$aMedicine, Chinese. 615 0$aHerbs$xTherapeutic use$xTesting. 676 $a615/.3210951 701 $aLeung$b Ping-Chung$f1941-$01612953 701 $aFong$b Harry Hong Sang$f1935-$01642271 701 $aXue$b Charlie Changli$01612954 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910807482803321 996 $aCurrent review of Chinese medicine$93986872 997 $aUNINA